Hilary C. Craig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hilary C. Craig has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Carel Wynand le Roux
University College Dublin, Dublin, Ireland
10 shared publications - Ebaa Al-Ozairi
Dasman Diabetes Institute Kuwait City Kuwait
4 shared publications - Alvin Mondoh
Diabetes Complications Research Centre, Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin 4, Ireland
3 shared publications Francisca Contreras
Diabetes Complications Research Centre, Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin 4, Ireland
3 shared publicationsD. Alsaeed
Dasman Diabetes Institute, Dasman, Kuwait
2 shared publicationsDalal Alsaeed
Dasman Diabetes Institute
2 shared publications
Latest Publications
- Open Access
Why Some Patients Choose Nutritional Therapy over Medications and Surgery in Obesity Care
Introduction: Obesity is a well-established risk factor for numerous chronic diseases, including type 2 diabetes, cardiovascular disease, and certain cancers. Obesity-related complications can be managed through nutritional therapy, pharmacotherapy, and surgical interventions, each capable of achieving weight loss of over 10%. Understanding patient preferences and the factors that influence treatment choices is crucial to enhancing adherence and effectiveness. This sub-study aimed to identify the factors shaping patient preferences for nutritional therapies in the context of available pharmacological and surgical options. Methods: A participatory action study recruited 43 patients aged 18–75 years with a BMI greater than 35 kg/m2 and obesity-related complications, including metabolic dysfunction, diabetes, hypertension, and chronic kidney disease. Participants viewed a 60-min informational video outlining treatment options before taking part in one-to-one interviews. Data were analysed using reflective thematic analysis. Results: This sub-study focuses on patients who expressed distinct attitudes toward nutritional therapy. Of the participants, 47% preferred nutritional therapy, 41% chose pharmacotherapy alone, and 6% selected a combination of pharmacotherapy and nutritional therapy. Five themes emerged to explain the preference for nutritional therapy: patient satisfaction, the personalised approach, effectiveness, empowerment, and side effects. Discussion: Nutritional therapies were still the most popular choice of many patients, suggesting there remain unmet needs of patients and that it should not be assumed that large majorities of patients with obesity only want pharmacotherapies or surgical therapies. Conclusion: Ensuring patients receive comprehensive information and regular guidance from nutritional experts is likely to further strengthen engagement.
Open AccessWhy Some Patients Choose Nutritional Therapy over Medications and Surgery in Obesity Care
Introduction: Obesity is a well-established risk factor for numerous chronic diseases, including type 2 diabetes, cardiovascular disease, and certain cancers. Obesity-related complications can be managed through nutritional therapy, pharmacotherapy, and surgical interventions, each capable of achieving weight loss of over 10%. Understanding patient preferences and the factors that influence treatment choices is crucial to enhancing adherence and effectiveness. This sub-study aimed to identify the factors shaping patient preferences for nutritional therapies in the context of available pharmacological and surgical options. Methods: A participatory action study recruited 43 patients aged 18–75 years with a BMI greater than 35 kg/m2 and obesity-related complications, including metabolic dysfunction, diabetes, hypertension, and chronic kidney disease. Participants viewed a 60-min informational video outlining treatment options before taking part in one-to-one interviews. Data were analysed using reflective thematic analysis. Results: This sub-study focuses on patients who expressed distinct attitudes toward nutritional therapy. Of the participants, 47% preferred nutritional therapy, 41% chose pharmacotherapy alone, and 6% selected a combination of pharmacotherapy and nutritional therapy. Five themes emerged to explain the preference for nutritional therapy: patient satisfaction, the personalised approach, effectiveness, empowerment, and side effects. Discussion: Nutritional therapies were still the most popular choice of many patients, suggesting there remain unmet needs of patients and that it should not be assumed that large majorities of patients with obesity only want pharmacotherapies or surgical therapies. Conclusion: Ensuring patients receive comprehensive information and regular guidance from nutritional experts is likely to further strengthen engagement.
- Open Access
- 4 March 2026
- Published by Elsevier in Obesity Pillars
- Vol. 18, 100256
Factors influencing patient preferences for obesity pharmacotherapy: The triangulation of semi-structured interviews, photovoice study and focus group discussions
- 4 March 2026
- Published by Elsevier in Obesity Pillars
- Vol. 18, 100256
Open AccessFactors influencing patient preferences for obesity pharmacotherapy: The triangulation of semi-structured interviews, photovoice study and focus group discussions
- Open Access
- 27 November 2025
- Published by Elsevier in Obesity Pillars
- Vol. 17
Logistics, effectiveness, safety, and accessibility: Factors determining obesity medication patient preferences from a photovoice analysis
- 27 November 2025
- Published by Elsevier in Obesity Pillars
- Vol. 17
Open AccessLogistics, effectiveness, safety, and accessibility: Factors determining obesity medication patient preferences from a photovoice analysis
- Open Access
- 16 June 2025
- Published by Elsevier in Obesity Pillars
- Vol. 15, 100187
How do patients choose between obesity medications: A thematic analysis
- 16 June 2025
- Published by Elsevier in Obesity Pillars
- Vol. 15, 100187
Open AccessHow do patients choose between obesity medications: A thematic analysis
- Open Access
- 24 April 2025
- Published by Springer Nature in International Journal of Obesity
- Vol. 49 (8) , 1554-1565
Factors influencing patients to choose one obesity treatment over another: a qualitative study
Background: When deciding a treatment option for the disease of obesity, knowing what the patient’s preferences are and what factors have influenced them can support healthcare professionals (HCPs) in tailoring their management plan. Little is known about patient preferences for obesity treatment. The present study was designed to identify factors that may influence these preferences. Objective: We aimed to identify factors affecting patient preferences and subsequent obesity treatment preferences among those seeking treatment for obesity-related disorders. Methods: Using a participatory action research design, we conducted World Café focus groups as part of a triangulation process with previously collected individual interviews and photovoice. Using purposive sampling, 12 patients with obesity complications of chronic kidney disease, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease took part. Thematic analysis was conducted to review themes, determine their significance, and report the findings. Results: Five themes emerged from the World Café on what influences patient treatment choice, which were 1) lack of resources, 2) healthcare professionals’ knowledge gaps, 3) lack of understanding, 4) emotional impact, and 5) support from family, friends, and HCPs. This data was then reviewed with the findings from the previous methodologies of one-to-one interviews and photovoice. Overall, four main themes were identified, which were 1) structural factors, 2) physical and emotional impact, 3) knowledge (of healthcare professionals and patients), and 4) support. Conclusion: This study demonstrates the importance of ensuring access to all treatment options by developing effective treatment plans with clear information for patients.
- 24 April 2025
- Published by Springer Nature in International Journal of Obesity
- Vol. 49 (8) , 1554-1565
Open AccessFactors influencing patients to choose one obesity treatment over another: a qualitative study
Background: When deciding a treatment option for the disease of obesity, knowing what the patient’s preferences are and what factors have influenced them can support healthcare professionals (HCPs) in tailoring their management plan. Little is known about patient preferences for obesity treatment. The present study was designed to identify factors that may influence these preferences. Objective: We aimed to identify factors affecting patient preferences and subsequent obesity treatment preferences among those seeking treatment for obesity-related disorders. Methods: Using a participatory action research design, we conducted World Café focus groups as part of a triangulation process with previously collected individual interviews and photovoice. Using purposive sampling, 12 patients with obesity complications of chronic kidney disease, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease took part. Thematic analysis was conducted to review themes, determine their significance, and report the findings. Results: Five themes emerged from the World Café on what influences patient treatment choice, which were 1) lack of resources, 2) healthcare professionals’ knowledge gaps, 3) lack of understanding, 4) emotional impact, and 5) support from family, friends, and HCPs. This data was then reviewed with the findings from the previous methodologies of one-to-one interviews and photovoice. Overall, four main themes were identified, which were 1) structural factors, 2) physical and emotional impact, 3) knowledge (of healthcare professionals and patients), and 4) support. Conclusion: This study demonstrates the importance of ensuring access to all treatment options by developing effective treatment plans with clear information for patients.
- Open Access
- 8 August 2024
- Published by Elsevier in Obesity Pillars
- Vol. 12, 100123
What influences patient decisions when selecting an obesity treatment?
- 8 August 2024
- Published by Elsevier in Obesity Pillars
- Vol. 12, 100123
Open AccessWhat influences patient decisions when selecting an obesity treatment?
- Open Access
- 1 May 2024
- Published by Springer Nature in International Journal of Obesity
- Vol. 49 (3) , 397-401
Factors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study
Objective: Obesity-related problems can now be managed with effective nutritional therapy, pharmacotherapy, and surgeries that achieve >10% weight loss. Assessing patient preferences, treatment choices, and factors affecting patients can improve treatment compliance and efficacy. Our aim was to identify factors affecting patient preference and subsequent choice of pharmacotherapy among those seeking treatment for obesity-related disorders. Methods: A participatory action study using purposeful sampling recruited 33 patients with obesity complications. They were referred to specialist clinics in non-alcoholic fatty liver disease, diabetes mellitus, hypertension, and chronic kidney disease. Sixteen males and seventeen females aged 18–70 years, with BMI > 35 kg/m2 were recruited. Before the interview, participants watched a 60-minute video explaining nutritional therapy, pharmacotherapy, and surgery in equipoise. Data were collected in semi-structured interviews; Reflective thematic analysis was used. This sub study focuses only on patients who expressed specific attitudes (positive or negative) towards pharmacotherapy. Results: Ten (30%) patients expressed a view on pharmacotherapy. Eight (24%) patients chose pharmacotherapy alone, whereas two (6%) patients chose pharmacotherapy combined with nutritional therapy. In this sub study focusing on pharmacotherapy, five themes were identified related to choosing whether or not to take medication: (1) attitudes towards pharmacotherapy, (2) attitudes toward size of obesity and its complications, (3) weighing the benefits and risks of treatment, (4) knowledge and reassurance of health professionals, and (5) costs associated with drug therapy. Conclusion: The primary concerns regarding pharmacotherapy for intentional weight loss were efficacy, side effects, lifelong dosing, pharmacokinetics, and cost. Providing access to information about all the pharmacotherapies and the benefits is likely to result in greater penetrance of treatment.
- 1 May 2024
- Published by Springer Nature in International Journal of Obesity
- Vol. 49 (3) , 397-401
Open AccessFactors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study
Objective: Obesity-related problems can now be managed with effective nutritional therapy, pharmacotherapy, and surgeries that achieve >10% weight loss. Assessing patient preferences, treatment choices, and factors affecting patients can improve treatment compliance and efficacy. Our aim was to identify factors affecting patient preference and subsequent choice of pharmacotherapy among those seeking treatment for obesity-related disorders. Methods: A participatory action study using purposeful sampling recruited 33 patients with obesity complications. They were referred to specialist clinics in non-alcoholic fatty liver disease, diabetes mellitus, hypertension, and chronic kidney disease. Sixteen males and seventeen females aged 18–70 years, with BMI > 35 kg/m2 were recruited. Before the interview, participants watched a 60-minute video explaining nutritional therapy, pharmacotherapy, and surgery in equipoise. Data were collected in semi-structured interviews; Reflective thematic analysis was used. This sub study focuses only on patients who expressed specific attitudes (positive or negative) towards pharmacotherapy. Results: Ten (30%) patients expressed a view on pharmacotherapy. Eight (24%) patients chose pharmacotherapy alone, whereas two (6%) patients chose pharmacotherapy combined with nutritional therapy. In this sub study focusing on pharmacotherapy, five themes were identified related to choosing whether or not to take medication: (1) attitudes towards pharmacotherapy, (2) attitudes toward size of obesity and its complications, (3) weighing the benefits and risks of treatment, (4) knowledge and reassurance of health professionals, and (5) costs associated with drug therapy. Conclusion: The primary concerns regarding pharmacotherapy for intentional weight loss were efficacy, side effects, lifelong dosing, pharmacokinetics, and cost. Providing access to information about all the pharmacotherapies and the benefits is likely to result in greater penetrance of treatment.
- Open Access
- 2 January 2024
- Published by Springer Nature in Research Square
Factors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study
Objective: Obesity-related problems can now be managed with effective nutritional therapy, pharmacotherapy, and surgeries that achieve >10% weight loss. Assessing patient preferences, treatment choices, and factors affecting patients can improve treatment compliance and efficacy. Our aim was to identify factors affecting patient preference and subsequent choice of pharmacotherapy among those seeking treatment for obesity-related disorders. Methods: A participatory action study using purposeful sampling recruited 33 patients with obesity complications. They were referred to specialist clinics in non-alcoholic fatty liver disease, diabetes mellitus, hypertension, and chronic kidney disease. Sixteen males and seventeen females aged 18-70 years, with BMI>35kg/m2 were recruited. Before the interview, participants watched a 60-minute video explaining nutritional therapy, pharmacotherapy, and surgery in equipoise. Data were collected in semi-structured interviews; Reflective thematic analysis was used. This sub study focuses only on patients who expressed specific attitudes (positive or negative) towards pharmacotherapy. Results: 30% of patients expressed a view on pharmacotherapy. 24% of all patients chose pharmacotherapy alone, whereas 6% chose pharmacotherapy combined with nutritional therapy. In this sub study focusing on pharmacotherapy, five themes were identified related to choosing whether or not to take medication: 1) attitudes towards pharmacotherapy, 2) attitudes toward size of obesity and its complications, 3) weighing the benefits and risks of treatment, 4) knowledge and reassurance of health professionals, and 5) costs associated with drug therapy. Conclusion: The primary concerns regarding pharmacotherapy for intentional weight loss were efficacy, side effects, lifelong dosing, pharmacokinetics, and cost. Providing access to information about all the pharmacotherapies and the benefits is likely to result in greater penetrance of treatment.
- 2 January 2024
- Published by Springer Nature in Research Square
Open AccessFactors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study
Objective: Obesity-related problems can now be managed with effective nutritional therapy, pharmacotherapy, and surgeries that achieve >10% weight loss. Assessing patient preferences, treatment choices, and factors affecting patients can improve treatment compliance and efficacy. Our aim was to identify factors affecting patient preference and subsequent choice of pharmacotherapy among those seeking treatment for obesity-related disorders. Methods: A participatory action study using purposeful sampling recruited 33 patients with obesity complications. They were referred to specialist clinics in non-alcoholic fatty liver disease, diabetes mellitus, hypertension, and chronic kidney disease. Sixteen males and seventeen females aged 18-70 years, with BMI>35kg/m2 were recruited. Before the interview, participants watched a 60-minute video explaining nutritional therapy, pharmacotherapy, and surgery in equipoise. Data were collected in semi-structured interviews; Reflective thematic analysis was used. This sub study focuses only on patients who expressed specific attitudes (positive or negative) towards pharmacotherapy. Results: 30% of patients expressed a view on pharmacotherapy. 24% of all patients chose pharmacotherapy alone, whereas 6% chose pharmacotherapy combined with nutritional therapy. In this sub study focusing on pharmacotherapy, five themes were identified related to choosing whether or not to take medication: 1) attitudes towards pharmacotherapy, 2) attitudes toward size of obesity and its complications, 3) weighing the benefits and risks of treatment, 4) knowledge and reassurance of health professionals, and 5) costs associated with drug therapy. Conclusion: The primary concerns regarding pharmacotherapy for intentional weight loss were efficacy, side effects, lifelong dosing, pharmacokinetics, and cost. Providing access to information about all the pharmacotherapies and the benefits is likely to result in greater penetrance of treatment.
- Open Access
- 29 October 2023
- Published by Wiley in Obesity Science & Practice
- Vol. 10 (1) , e720
Patient perspectives about treatment preferences for obesity with complications
Objective: Obesity and many of its comorbidities can be improved by nutritional therapy, lifestyle modification, pharmacotherapy, and surgical intervention. Relatively little is known about patients' preferences for the range of obesity treatments. The present study was undertaken to identify factors that may influence these preferences. By evaluating patient‐preferred treatment options and factors influencing patients, treatment adherence and efficacy may be improved. Our objective was to identify factors that influence patient preferences and subsequent choice of obesity treatment among those seeking treatment for obesity‐related complications.Methods: Participatory action research, using purposeful sampling, was used to recruit 33 patients with obesity complications. Recruitment took place in specialist clinics for non‐alcoholic fatty liver disease, diabetes, hypertension, and chronic kidney disease. Sixteen males and 17 females aged 18–70 years with a BMI>35 kg/m2 were recruited. Prior to the interview, participants watched a 60‐min video explaining nutritional therapies, pharmacotherapies, and surgical therapies in equipoise. Data were collected in one‐to‐one semi‐structured interviews using zoom or the telephone; reflective thematic analysis was used.Results: Four themes emerged: 1) structural factors, 2) autonomy, 3) interaction with formal care, and 4) the emotional and physical consequences of obesity. 39% of participants preferred nutritional therapy with support from medical professionals. 27% chose bariatric surgery. 24% chose pharmacotherapy alone, while 6% chose pharmacotherapy combined with nutritional therapy, 3% of participants wanted no intervention.Conclusion: The challenges can be addressed by increasing support for healthcare professionals toward enhancing both their knowledge and the health literacy of patients. Future research should focus on improving access to treatment pathways for patients as well as developing health literacy programs and educational programs for healthcare professionals.
- 29 October 2023
- Published by Wiley in Obesity Science & Practice
- Vol. 10 (1) , e720
Open AccessPatient perspectives about treatment preferences for obesity with complications
Objective: Obesity and many of its comorbidities can be improved by nutritional therapy, lifestyle modification, pharmacotherapy, and surgical intervention. Relatively little is known about patients' preferences for the range of obesity treatments. The present study was undertaken to identify factors that may influence these preferences. By evaluating patient‐preferred treatment options and factors influencing patients, treatment adherence and efficacy may be improved. Our objective was to identify factors that influence patient preferences and subsequent choice of obesity treatment among those seeking treatment for obesity‐related complications.Methods: Participatory action research, using purposeful sampling, was used to recruit 33 patients with obesity complications. Recruitment took place in specialist clinics for non‐alcoholic fatty liver disease, diabetes, hypertension, and chronic kidney disease. Sixteen males and 17 females aged 18–70 years with a BMI>35 kg/m2 were recruited. Prior to the interview, participants watched a 60‐min video explaining nutritional therapies, pharmacotherapies, and surgical therapies in equipoise. Data were collected in one‐to‐one semi‐structured interviews using zoom or the telephone; reflective thematic analysis was used.Results: Four themes emerged: 1) structural factors, 2) autonomy, 3) interaction with formal care, and 4) the emotional and physical consequences of obesity. 39% of participants preferred nutritional therapy with support from medical professionals. 27% chose bariatric surgery. 24% chose pharmacotherapy alone, while 6% chose pharmacotherapy combined with nutritional therapy, 3% of participants wanted no intervention.Conclusion: The challenges can be addressed by increasing support for healthcare professionals toward enhancing both their knowledge and the health literacy of patients. Future research should focus on improving access to treatment pathways for patients as well as developing health literacy programs and educational programs for healthcare professionals.
- Open Access
The Concept of Healthy Behaviours in Obesity May Have Unintended Consequences
Obesity has become a global epidemic, representing a major health crisis, with a significant impact both in human and financial terms. Obesity was originally seen as a condition, not a disease, which was considered self-inflicted. Thus, it was understandable that a simplistic approach, such as eat less and move more was proposed to manage obesity. Over the last 25 years, the perception of obesity has been gradually changing and the awareness has risen that it is a disease in its own right and not just a precipitating factor for type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), etc. Creation of a comprehensive algorithm for the management of obesity needs to be informed by an in-depth understanding of the issues impacting the provision of treatment. Promotion of healthy behaviours is essential to help the population become healthier, but these are not obesity treatment strategies. Twenty percent of patients with obesity may respond to approaches based on healthy behaviour, but the 80% who do not respond should not be stigmatised but rather their treatment should be escalated. The unintended consequences of promoting healthy behaviours to patients with obesity can be mitigated by understanding that obesity is likely to be a subset of complex diseases, that require chronic disease management. Once the biology of the disease has been addressed, then healthy behaviours may play an invaluable role in optimising self-care within a chronic disease management strategy.
Open AccessThe Concept of Healthy Behaviours in Obesity May Have Unintended Consequences
Obesity has become a global epidemic, representing a major health crisis, with a significant impact both in human and financial terms. Obesity was originally seen as a condition, not a disease, which was considered self-inflicted. Thus, it was understandable that a simplistic approach, such as eat less and move more was proposed to manage obesity. Over the last 25 years, the perception of obesity has been gradually changing and the awareness has risen that it is a disease in its own right and not just a precipitating factor for type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), etc. Creation of a comprehensive algorithm for the management of obesity needs to be informed by an in-depth understanding of the issues impacting the provision of treatment. Promotion of healthy behaviours is essential to help the population become healthier, but these are not obesity treatment strategies. Twenty percent of patients with obesity may respond to approaches based on healthy behaviour, but the 80% who do not respond should not be stigmatised but rather their treatment should be escalated. The unintended consequences of promoting healthy behaviours to patients with obesity can be mitigated by understanding that obesity is likely to be a subset of complex diseases, that require chronic disease management. Once the biology of the disease has been addressed, then healthy behaviours may play an invaluable role in optimising self-care within a chronic disease management strategy.